GB9226047D0 - Therapeutic use - Google Patents
Therapeutic useInfo
- Publication number
- GB9226047D0 GB9226047D0 GB929226047A GB9226047A GB9226047D0 GB 9226047 D0 GB9226047 D0 GB 9226047D0 GB 929226047 A GB929226047 A GB 929226047A GB 9226047 A GB9226047 A GB 9226047A GB 9226047 D0 GB9226047 D0 GB 9226047D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic use
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929226047A GB9226047D0 (en) | 1992-12-14 | 1992-12-14 | Therapeutic use |
US08/496,118 US5830854A (en) | 1992-12-14 | 1995-06-27 | Method of treating cystic fibrosis using a tachykinin receptor antagonist |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929226047A GB9226047D0 (en) | 1992-12-14 | 1992-12-14 | Therapeutic use |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9226047D0 true GB9226047D0 (en) | 1993-02-10 |
Family
ID=10726584
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB929226047A Pending GB9226047D0 (en) | 1992-12-14 | 1992-12-14 | Therapeutic use |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB9226047D0 (en) |
-
1992
- 1992-12-14 GB GB929226047A patent/GB9226047D0/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9210393D0 (en) | Therapeutic agents | |
GB9211193D0 (en) | Therapeutic agents | |
GB9215527D0 (en) | Therapeutic agents | |
GB9203790D0 (en) | Therapeutic agents | |
GB9206266D0 (en) | Therapeutic agents | |
GB9209518D0 (en) | Therapeutic agents | |
GB9208463D0 (en) | Therapeutic agents | |
GB9200781D0 (en) | Therapeutic agents | |
GB9208116D0 (en) | Therapeutic agents | |
GB9226047D0 (en) | Therapeutic use | |
GB9226056D0 (en) | Therapeutic use | |
GB9220714D0 (en) | Therapeutic use | |
GB9222633D0 (en) | Therapeutic agetns | |
GB9226728D0 (en) | Therapeutic combination | |
GB9210270D0 (en) | Therapeutic combinations | |
GB9216088D0 (en) | Therapeutic combinations | |
GB9210256D0 (en) | Therapeutic combinations | |
GB9206157D0 (en) | Therapeutic agents | |
GB9203997D0 (en) | Therapeutic agents | |
GB9204578D0 (en) | Therapeutic agents | |
GB9205288D0 (en) | Therapeutic agents | |
GB9205294D0 (en) | Therapeutic agents | |
GB9205482D0 (en) | Therapeutic agents | |
GB9204119D0 (en) | Therapeutic agents | |
GB9203998D0 (en) | Therapeutic agents |